Effects of antimicrobial peptides on Staphylococcus aureus growth and biofilm formation in vitro following isolation from implant-associated infections

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 1546-1551

  Zhao, Guangfeng ^a   Zhong, Huiming ^a   Zhang, Mao ^a   Hong, Yucai ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antimicrobial peptide; Biofilm; Implant associated infection; Titanium

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TITANIUM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIOFILM; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE INFECTION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INCUBATION TIME; MASS SPECTROMETRY; NONHUMAN; ORTHOPEDIC IMPLANT; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 84923039590     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Trampuz A and Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis 2006; 19: 349-356.
2. Neut D, van Horn JR, van Kooten TG, van der Mei HC and Busscher HJ. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin. Orthop. Relat Res 2003; 413: 261-268.
3. Carson CC 3rd. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004; 171: 1611-1614.
4. Mombelli A and Lang N. Antimicrobial treatment of peri-implant infections. Clin Oral Implants Res 1992; 3: 162-168.
5. Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005; 57: 1539-1550.
6. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720.
7. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480: 147-150.
8. Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock RE and Wang R. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 2010; 31: 9519-9526.
9. Costa F, Carvalho IF, Montelaro RC, Gomes P and Martins MC. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater 2011; 7: 1431-1440.
10. Gao G, Lange D, Hilpert K, Kindrachuk J, Zou Y, Cheng JT, Kazemzadeh-Narbat M, Yu K, Wang R, Straus SK, Brooks DE, Chew BH, Hancock RE, Kizhakkedathu JN. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 2011; 32: 3899-3909.
11. Lu S. Immobilization of antimicrobial peptides onto titanium surfaces. University of British Columbia. 2009.
12. Basu A, Mishra B and Leong SS. Immobilization of polybia-MPI by allyl glycidyl ether based brush chemistry to generate a novel antimicrobial surface. J Materials Chem B 2013; 1: 4746-4755.
13. Zimmerli W, Widmer AF, Blatter M, Frei R and Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. JAMA 1998; 279: 1537-1541.
14. Deck MK, Anderson ES, Buckner RJ, Colasante G, Coull JM, Crystal B, Della Latta P, Fuchs M, Fuller D and Harris W. Multicenter evaluation of the Staphylococcus QuickFISH method for simultaneous identification of Staphylococcus aureus and coagulase-negative staphylococci directly from blood culture bottles in less than 30 minutes. J Clin Microbiol 2012; 50: 1994-1998.
15. Gupta S, Singh R, Kosaraju K, Bairy I and Ramaswamy B. A study of antibacterial and antifungal properties of human cerumen. Indian J Otology 2012; 18.
16. Biancalana FS, Lyra L, Moretti ML, Kamei K and Schreiber AZ. Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine. Mycopathologia 2011; 172: 279-285.
17. Kazemzadeh-Narbat M, Noordin S, Masri BA, Garbuz DS, Duncan CP, Hancock RE and Wang R. Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium. J Biomed Mater Res B Appl Biomater 2012; 100: 1344-1352.
18. Gruenheid S and Moual H. Resistance to antimicrobial peptides in Gram-negative bacteria. FEMS Microbiol Lett 2012; 330: 81-89.
19. Park Y and Hahm KS. Antimicrobial peptides (AMPs): peptide structure and mode of action. J Biochem Mol Biol 2005; 38: 507-516.
20. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G and Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999; 274: 8405-8410.
21. Ellermeier CD and Losick R. Evidence for a novel protease governing regulated intramem brane proteolysis and resistance to antimicrobial peptides in Bacillus subtilis. Genes Dev 2006; 20: 1911-1922.
22. Zasloff M. Antimicrobial peptides in health and disease. New Eng J Med 2002; 347: 1199-1199.
23. Sobczak M, Dębek C, Olędzka E and Kozłowski R. Polymeric systems of antimicrobial peptides-strategies and potential applications. Molecules 2013; 18: 14122-14137.
24. Glinel K, Thebault P, Humblot V, Pradier CM and Jouenne T. Antibacterial surfaces developed from bio-inspired approaches. Acta Biomater 2012; 8: 1670-1684.
25. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR and Otto M. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004; 6: 269-275.
26. Costerton J, Montanaro L and Arciola C. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28: 1062-1068.
27. Mah TF and O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-39.
28. Park SC, Park Y and Hahm KS. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 2011; 12: 5971-5992.
29. Chennupati SK, Chiu AG, Tamashiro E, Banks CA, Cohen MB, Bleier BS, Kofonow JM, Tam E and Cohen NA. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy 2009; 23: 46-51.
30. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005; 3: 238-250.
31. Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC and Mietzner TA. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother 2005; 49: 3208-3216.